Flow cytometry-based gating strategy for FLS phenotyping FLS isolated from the hind paws of hTNF-α tg mice were cultivated until passage 5 before phenotyping. The latter was carried out using flow cytometry analysis, whereas cells that were CD11b − (A), CD54 + (B), and CD106 + (C) were considered to be FLS. Unstained and isotype-stained samples served as controls. Depicted is exemplary data (histogram overlay) for one hTNF-α tg-derived FLS cell pool.
Supplementary Figure 2: Flow cytometry-based gating strategy for analysis of macrophage polarization
Bone marrow cells of the long bones of hTNFα tg mice were isolated and differentiated with 5ng/ml M-CSF with frequent media changes. 24h before harvest, cells were treated with cytokine cocktails for differentiation into polarized macrophages. Afterwards, the phenotype of the macrophages was determined by multicolour flow cytometry. After exclusion of duplets (A), viable cells were gated according to their FSC/SSC properties (B) and macrophages were consecutively identified as being positive for F4/80 and CD11b(C). D-G show fluorescent minus one (FMO) stainings for gate placement of macrophage phenotype analyses. Here, pre-gated macrophages (C) were further examined with regards to the respective pro-and anti-inflammatory surface markers MHCII (D), CD86 (E), CD80 (F), and CD206 (G), respectively.
Supplementary Figure 3: Flow cytometry-and quantitative PCR (qPCR)-based characterization of macrophage cultures
Bone marrow cells from the long bones of hTNFα tg mice were isolated and differentiated with 5ng/ml M-CSF with frequent media changes. 24h before harvest, cells were treated with cytokine cocktails for differentiation into M0 (5ng/ml M-CSF), M1 (4ng/ml GM-CSF; 20ng/ml IFNγ; 20ng/ml LPS), or M2 (5ng/ml M-CSF; 20ng/ml IL4) polarized macrophages. A-D show flow cytometry-based and E-G qPCR-based identification of macrophage phenotypes, respectively. M2 stimulated macrophages were considered to be CD206 + (A) as well as Arg1+ (E) whereas, M1 polarized ones where considered to be CD80 + (B), MHCII + (C), CD86 + (D), Nos2 + (F), and TNFα + (G).
